Berry Consultants   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Austin TX United States (2000)

Organization Overview

First Clinical Trial
2008
NCT00734474
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Berry Consultants

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aphasia, Primary Progressive (Phase 2)

Dementia (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Frontotemporal Dementia (Phase 2)

Pick Disease of the Brain (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 23